Please assess the completion status of the following clinical trial:

Trial Title: StimRouter™ for Pain Management in Post-stroke Shoulder Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female age ≥18 years and confirmed diagnosis of stroke~* Competent to provide consent and comply with study requirements~* Minimum 3 months of severe chronic focal post-stroke shoulder pain~* Stable regimen of pain medications for \>4 weeks prior to implant and willing to maintain equivalent dosage throughout the study~* A mean score of \> 4 on the Brief Pain Inventory short form, question 3 (BPI-SF3)~* Capable and willing to follow all study-related procedures~* Able to tolerate surface stimulation as demonstrated by motor level response at shoulder~Exclusion Criteria:~* Patients who decline to provide written consent or to attend follow-up visits~* Shoulder pathology (e.g. rotator cuff tear, frozen shoulder etc) at target limb~* Evidence of a primary central or regional pain pattern inclusive of shoulder~* Diagnosed/confirmed shoulder dysfunction~* Botox or other neurolytic agent injections in last 3 months~* Any confounding neurologic conditions affecting the upper limb~* Evidence or history of skin infections~* History of adverse reactions to local anesthetics (e.g. lidocaine) or adhesives~* Patients who have an active systemic infection or are immunocompromised~* Patients who are pregnant, intend to become pregnant, are breastfeeding or of child-bearing potential and not practicing a medically-approved method of birth control~* Currently requiring or likely to require Magnetic Resonance Imaging (MRI) within the MRI exclusion zone defined as within 50cm of the iso-center or 16 cm of the MR coil as measured from the edge of the MRI coil.~* Any metallic implant in the immediate area intended for implant (e.g. TSR)~* Has demand-type cardiac pacemaker, defibrillator, or electrical nerve implant~* Potential need for diathermy at the implant site~* Potential need for therapeutic ultrasound at the implant site~* Patients who have already been implanted with StimRouter TM prior to study enrollment~* Presence of a documented condition or abnormality that could compromise the safety of the patient~* Life expectancy of less than 1 year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- StimRouter Neuromodulation System (Type: EXPERIMENTAL): All eligible patients who are enrolled in this study will be treated with StimRouter stimulation therapy as part of standard of care for the entire duration of the study (6 months) and observed for post-market population-specific data.~Standard recommended stimulation parameters for post-stroke shoulder pain include settings to elicit sensory response (paresthesia) as well as motor response (muscle contraction).

Based on this trial design, predict the completion outcome and termination type (if applicable).